GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.
You can purchase shares of GlycoMimetics (NASDAQ:GLYC) through any online brokerage.
Other companies in GlycoMimetics’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Imunon (NASDAQ:IMNN) and Evaxion Biotech (NASDAQ:EVAX).
GlycoMimetics has a consensus price target of $12.00.
The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.2586 last updated January 17, 2025 at 5:07 PM EST.
There are no upcoming dividends for GlycoMimetics.
GlycoMimetics’s Q4 earnings are confirmed for Wednesday, March 26, 2025.
There is no upcoming split for GlycoMimetics.
GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.